I think it is reasonable for Illumina to have the upgrade path... it is just unfortunate that many facilities are possibly facing a difficult situation. It is also unfortunate that many machines were recently upgraded to the 2500 and it wasn't clear at that time that the 2500 upgrade was substantially different from a factory-built 2500.
Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
-
Originally posted by BBoy View PostOr when a car model in 2013 had some gizmo and you find out that it simply was not compatible with the older design? Betcha you don't expect auto makers to list what in the new model is not backward compatible with the old model.
Comment
-
Originally posted by BBoy View PostSo how many of you bought video players or Rokus in 2012 and tried to hook them up to 3+ year old TV without HDMI ports? Betcha you did not think you were screwed by the TV maker and we're "entitled" to trade in the TV for a "rreasonable cost". Or when a car model in 2013 had some gizmo and you find out that it simply was not compatible with the older design? Betcha you don't expect auto makers to list what in the new model is not backward compatible with the old model.
Frankly the tone of this discussion is more than a bit odd. True, commrrcia equipment is held to a higher standard but expecting the upgrade of a 3 year old major component is not exactly reasonable.
Secondly, by having the new kits be unusable on the older machines, Illumina is purposely starving themselves of revenue. It is the reagent kits that make most of the money -- there aren't that many HiSeqs around the world.
Lastly, users are disappointed in this thread because all upgraded machines are thought to be "HiSeq 2500"s except for some speed issues. Sequencing centers paid money to get their 2000s upgraded (many of them happened this year!!), and there was no guidance from the company on how these won't be able to use new kits. If these centers had known, many of them would have passed on the upgrade and saved up for a brand new machine.
Comment
Latest Articles
Collapse
-
by seqadmin
The first FDA-approved CRISPR-based therapy marked the transition of therapeutic gene editing from a dream to reality1. CRISPR technologies have streamlined gene editing, and CRISPR screens have become an important approach for identifying genes involved in disease processes2. This technique introduces targeted mutations across numerous genes, enabling large-scale identification of gene functions, interactions, and pathways3. Identifying the full range...-
Channel: Articles
08-27-2024, 04:44 AM -
-
by seqadmin
Sequencing mRNA provides a snapshot of cellular activity, allowing researchers to study the dynamics of cellular processes, compare gene expression across different tissue types, and gain insights into the mechanisms of complex diseases. “mRNA’s central role in the dogma of molecular biology makes it a logical and relevant focus for transcriptomic studies,” stated Sebastian Aguilar Pierlé, Ph.D., Application Development Lead at Inorevia. “One of the major hurdles for...-
Channel: Articles
08-07-2024, 12:11 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 08-27-2024, 04:40 AM
|
0 responses
16 views
0 likes
|
Last Post
by seqadmin
08-27-2024, 04:40 AM
|
||
New Single-Molecule Sequencing Platform Introduces Advanced Features for High-Throughput Genomics
by seqadmin
Started by seqadmin, 08-22-2024, 05:00 AM
|
0 responses
293 views
0 likes
|
Last Post
by seqadmin
08-22-2024, 05:00 AM
|
||
Started by seqadmin, 08-21-2024, 10:49 AM
|
0 responses
135 views
0 likes
|
Last Post
by seqadmin
08-21-2024, 10:49 AM
|
||
Started by seqadmin, 08-19-2024, 05:12 AM
|
0 responses
124 views
0 likes
|
Last Post
by seqadmin
08-19-2024, 05:12 AM
|
Comment